Search for: "Proxy Biomedical Inc"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
13 Sep 2010, 11:48 am
On September 8, biomedical testing company Beckman Coulter, Inc. [read post]
17 Nov 2011, 5:00 am
According to the company's proxy statement: Arthur D. [read post]
11 Sep 2011, 9:50 pm
Bard, Inc., Covington, GA) Polyform Synthetic Mesh (Proxy Biomedical, Ltd., Galway, Ireland) The FDA 501(k) premarket notification system, a "fast track" in bringing a medical device to market, is again criticized with this mesh debacle. [read post]
11 Sep 2011, 9:50 pm
Bard, Inc., Covington, GA) Polyform Synthetic Mesh (Proxy Biomedical, Ltd., Galway, Ireland) The FDA 501(k) premarket notification system, a "fast track" in bringing a medical device to market, is again criticized with this mesh debacle. [read post]
31 Aug 2011, 10:38 am
Bard, Inc., Covington, GA Poloyform Synthetic Mesh by Proxy Biomedical, Ltd., Galway, Ireland Finally, Public Citizen requested that the FDA require that all non-absorbable surgical mesh products specifically designed for the transvaginal repair of POP be classified as a class III device and be approved for marketing under a premarket approval application. [read post]
18 Jan 2012, 4:27 am
PROXY BIOMEDICAL LTD. [read post]
30 Aug 2011, 1:46 pm
Bard, and Proxy Biomedical. [read post]
30 Aug 2011, 1:46 pm
Bard, and Proxy Biomedical. [read post]
29 Sep 2011, 8:39 am
Bard, Coloplast, Mentor Corporation, and Proxy Biomedical. [read post]
9 Nov 2017, 9:04 am
Using the list above as a proxy for familiar common terms was helpful in picking a cutoff point even though a significant portion of the sample did not involve computer-related innovation. [read post]
27 Mar 2023, 9:01 pm
This figure is significantly lower than in 2016, when the Delaware Court of Chancery effectively put an end to the practice of disclosure-only settlements in In re Trulia Inc. [read post]
17 Nov 2018, 12:10 pm
Biomedical scientists continue to interpret 95% confidence intervals, at least in part, as to whether they show “significance” by excluding the null hypothesis value of no risk difference or of risk ratios equal to 1.0. [read post]
14 Aug 2011, 9:11 am
., Inc., 509 U.S. 579 (1993). [read post]
